As of 2026-03-14, the Relative Valuation of Novacyt SA (ALNOV.PA) is (13.75) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.38 EUR, the upside of Novacyt SA based on Relative Valuation is -3681.3%.
The range of the Relative Valuation is (14.14) - (16.12) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.9x - 54.8x | 33.5x |
| Forward P/E multiples | 26.6x - 37.4x | 30.4x |
| Fair Price | (14.14) - (16.12) | (13.75) |
| Upside | -3783.3% - -4296.7% | -3681.3% |
| Date | P/E |
| 2026-03-12 | -0.90 |
| 2026-03-11 | -0.89 |
| 2026-03-10 | -0.89 |
| 2026-03-09 | -0.90 |
| 2026-03-06 | -0.89 |
| 2026-03-05 | -0.91 |
| 2026-03-04 | -0.90 |
| 2026-03-03 | -0.92 |
| 2026-03-02 | -0.96 |
| 2026-02-27 | -0.94 |
| 2026-02-26 | -0.97 |
| 2026-02-25 | -0.93 |
| 2026-02-24 | -0.92 |
| 2026-02-23 | -0.90 |
| 2026-02-20 | -0.91 |
| 2026-02-19 | -0.90 |
| 2026-02-18 | -0.93 |
| 2026-02-17 | -0.92 |
| 2026-02-16 | -0.92 |
| 2026-02-13 | -0.95 |
| 2026-02-12 | -0.91 |
| 2026-02-11 | -0.93 |
| 2026-02-10 | -0.95 |
| 2026-02-09 | -0.91 |
| 2026-02-06 | -0.92 |
| 2026-02-05 | -0.95 |
| 2026-02-04 | -0.94 |
| 2026-02-03 | -0.96 |
| 2026-02-02 | -0.96 |
| 2026-01-30 | -0.95 |
| 2026-01-29 | -0.97 |
| 2026-01-28 | -0.97 |
| 2026-01-27 | -0.97 |
| 2026-01-26 | -1.02 |
| 2026-01-23 | -0.94 |
| 2026-01-22 | -0.91 |
| 2026-01-21 | -0.92 |
| 2026-01-20 | -0.92 |
| 2026-01-19 | -0.92 |
| 2026-01-16 | -0.91 |
| 2026-01-15 | -0.94 |
| 2026-01-14 | -0.92 |
| 2026-01-13 | -0.94 |
| 2026-01-12 | -0.94 |
| 2026-01-09 | -0.93 |
| 2026-01-08 | -0.93 |
| 2026-01-07 | -0.95 |
| 2026-01-06 | -0.94 |
| 2026-01-05 | -0.98 |
| 2026-01-02 | -0.98 |